ResearcherFirst Affiliated Hospital of Soochow UniversityNo recent work listed

Chen Dai

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5157871702. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 2 papers

Papers 2

MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12935-020-01185-z ↗
Molecular Screening for Nigericin Treatment in Pancreatic Cancer by High-Throughput RNA Sequencing. Co-author DOI 10.3389/fonc.2020.01282 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhihua Xu · 2 shared papers, 2020 · strength 0.27
- Paper MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcin… DOI 10.1186/s12935-020-01185-z ↗
- Paper Molecular Screening for Nigericin Treatment in Pancreatic Cancer by High-Throughput RNA Sequencing. DOI 10.3389/fonc.2020.01282 ↗
Mengxian Jin · 1 shared paper, 2020 · strength 0.16
- Paper MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcin… DOI 10.1186/s12935-020-01185-z ↗
Ye Xu · 1 shared paper, 2020 · strength 0.11
- Paper Molecular Screening for Nigericin Treatment in Pancreatic Cancer by High-Throughput RNA Sequencing. DOI 10.3389/fonc.2020.01282 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.